In the pandemic coronavirus disease 2019 (COVID-19) era, the need to use preventive-curative treatments is compelling. A series of non-pharmacological compounds, including oligo-elements, vitamins, nutraceuticals, and bacteriotherapy, might affect the risk of COVID-19, both reinforcing the immune system and improving the inflammation resolution during respiratory infections. Non-pharmacological remedies are very popular and usually have no relevant side effects. Bacterial and natural products may potentiate the immune system against respiratory viruses. Moreover, these compounds also exert antiinflammatory and antioxidant activity. Consequently, these non-chemical remedies could be prescribed to build up the immune defence and adequately treat the upper respiratory infection. In this way, natural compounds could be used to manage people in the pandemic COVID-19 era.

Passali, D., Bellussi, L.m., Passali, F.m., De Hoyos, R., Di Girolamo, S., Ciprandi, G. (2021). Prevention and treatment of upper respiratory diseases in the pandemic COVID-19 era. JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS, 35(1), 3-8 [10.23812/21-1supp2-2].

Prevention and treatment of upper respiratory diseases in the pandemic COVID-19 era

Passali F. M.;Di Girolamo S.
Investigation
;
2021-01-01

Abstract

In the pandemic coronavirus disease 2019 (COVID-19) era, the need to use preventive-curative treatments is compelling. A series of non-pharmacological compounds, including oligo-elements, vitamins, nutraceuticals, and bacteriotherapy, might affect the risk of COVID-19, both reinforcing the immune system and improving the inflammation resolution during respiratory infections. Non-pharmacological remedies are very popular and usually have no relevant side effects. Bacterial and natural products may potentiate the immune system against respiratory viruses. Moreover, these compounds also exert antiinflammatory and antioxidant activity. Consequently, these non-chemical remedies could be prescribed to build up the immune defence and adequately treat the upper respiratory infection. In this way, natural compounds could be used to manage people in the pandemic COVID-19 era.
2021
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/31 - OTORINOLARINGOIATRIA
English
Con Impact Factor ISI
COVID-19
bacteriotherapy
microbiota
nutraceuticals
oligo-elements
upper respiratory infections
Dietary Supplements
Humans
SARS-CoV-2
Vitamins
COVID-19
Pandemics
Passali, D., Bellussi, L.m., Passali, F.m., De Hoyos, R., Di Girolamo, S., Ciprandi, G. (2021). Prevention and treatment of upper respiratory diseases in the pandemic COVID-19 era. JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS, 35(1), 3-8 [10.23812/21-1supp2-2].
Passali, D; Bellussi, Lm; Passali, Fm; De Hoyos, R; Di Girolamo, S; Ciprandi, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/290293
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact